Superworth

iBio EPS IBIO

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.33
Latest quarter, Q4 FY26
−$0.07
Fiscal year 2026
−$0.33

iBio's earnings per share was −$0.33 over the twelve months to Jun 30, 2026.

In its latest quarter, Q4 FY26, it was −$0.07.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026−$0.33n/a
FY2025−$1.79n/a
FY2024−$10.97n/a
FY2023−$126.30n/a
FY2022−$100.20n/a
FY2021−$65.00n/a
FY2020−$495.00n/a
FY2019−$470.00n/a
FY2018−$780.00n/a
FY2017−$800.00n/a
FY2016−$600.00n/a
FY2015−$400.00n/a
FY2014−$300.00n/a
FY2013−$600.00n/a
FY2012−$700.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q4 FY26−$0.07n/a−$0.33
Q3 FY26−$0.06n/a−$0.62
Q2 FY26−$0.09n/a−$1.05
Q1 FY26−$0.11n/a−$1.44
Q4 FY25−$0.36n/a−$1.79
Q3 FY25−$0.49n/a−$2.33
Q2 FY25−$0.48n/a−$2.69
Q1 FY25−$0.46n/a−$6.63
Q4 FY24−$0.90n/a−$10.97
Q3 FY24−$0.85n/a−$15.87
Q2 FY24−$4.42n/a−$26.09
Q1 FY24−$4.80n/a−$90.10

Against its peers

Companies in Drug Manufacturers - General nearest iBio's size, closest first, today.

CompanyEPS, 12 monthsGrowth
IBIOiBio−$0.33
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on iBio

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.